Speaker illustration

Doctor Raphael Wurm

Medical University of Vienna, Department of Internal Medicine II, Division of Cardiology, Vienna (Austria)

RAS Antagonists and beta blockers stabilize HbA1c and improve insulin resistance in patients with diabetes free from cardiac disease

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Diabetes and the Heart

Session: Diabetes and the Heart

Thumbnail

Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles

Event: ESC CONGRESS 2016

Topic: Cardiotoxicity of drugs

Session: Cancer and cardiotoxicity: from bench to bedside

Thumbnail

Fingerprint of the renin-angiotensin-system during ARNI therapy in patients with systolic heart failure

Event: ESC CONGRESS 2016

Topic: Pharmacologic therapy

Session: Drug therapy of heart failure

Thumbnail

This platform is supported by

logo Novo Nordisk